Translational Genito-Urinary Cancer Research
Selected Publications
Wetterauer, Christian, Matthias, Mark, Pueschel, Heike, Deckart, Alexander, Bubendorf, Lukas, Mortezavi, Ashkan, Arbelaez, Emilio, Jean Winkel, David, Heye, Tobias, Boll, Daniel T., Merkle, Elmar, Hayoz, Stefanie, Seifert, Helge H., & (2024). Opportunistic Prostate Cancer Screening with Biparametric Magnetic Resonance Imaging (VISIONING). European Urology Focus, 10(2), 332–338. https://doi.org/10.1016/j.euf.2024.02.006
Wetterauer, Christian, Matthias, Mark, Pueschel, Heike, Deckart, Alexander, Bubendorf, Lukas, Mortezavi, Ashkan, Arbelaez, Emilio, Jean Winkel, David, Heye, Tobias, Boll, Daniel T., Merkle, Elmar, Hayoz, Stefanie, Seifert, Helge H., & (2024). Opportunistic Prostate Cancer Screening with Biparametric Magnetic Resonance Imaging (VISIONING). European Urology Focus, 10(2), 332–338. https://doi.org/10.1016/j.euf.2024.02.006
Flury-Sutter, Sarah, Heuzeroth, Frederick, Arbelaez, Emilio, Bubendorf, Lukas, Püschel, Heike, Hayoz, Stefanie, & (2024). Efficacy and tolerability of bacillus Calmette-Guérin strain Russia for the treatment of non-muscle-invasive bladder cancer: Analysis of a prospective registry [Journal-article]. Canadian Urological Association Journal, 18(7). https://doi.org/10.5489/cuaj.8552
Flury-Sutter, Sarah, Heuzeroth, Frederick, Arbelaez, Emilio, Bubendorf, Lukas, Püschel, Heike, Hayoz, Stefanie, & (2024). Efficacy and tolerability of bacillus Calmette-Guérin strain Russia for the treatment of non-muscle-invasive bladder cancer: Analysis of a prospective registry [Journal-article]. Canadian Urological Association Journal, 18(7). https://doi.org/10.5489/cuaj.8552
Garioni, Michele, Tschan, Viviane J., Blukacz, Lauriane, Nuciforo, Sandro, Parmentier, Romuald, Roma, Luca, Coto-Llerena, Mairene, Pueschel, Heike, Piscuoglio, Salvatore, Vlajnic, Tatjana, Stenner, Frank, Seifert, Hans-Helge, , Bubendorf, Lukas, & Le Magnen, Clémentine. (2023). Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer. Npj Precision Oncology, 7(1). https://doi.org/10.1038/s41698-023-00466-w
Garioni, Michele, Tschan, Viviane J., Blukacz, Lauriane, Nuciforo, Sandro, Parmentier, Romuald, Roma, Luca, Coto-Llerena, Mairene, Pueschel, Heike, Piscuoglio, Salvatore, Vlajnic, Tatjana, Stenner, Frank, Seifert, Hans-Helge, , Bubendorf, Lukas, & Le Magnen, Clémentine. (2023). Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer. Npj Precision Oncology, 7(1). https://doi.org/10.1038/s41698-023-00466-w
, Thalmann GN, Lucca I, Kwiatkowski M, Wirth GJ, Strebel RT, Engeler D, Pedrazzini A, Hüttenbrink C, Schultze-Seemann W, Torpai R, Bubendorf L, Wicki A, Roth B, Bosshard P, Püschel H, Boll DT, Hefermehl L, Roghmann F, et al. (2022). A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14. European Urology Oncology, 5(2), 195–202. https://doi.org/10.1016/j.euo.2021.12.006
, Thalmann GN, Lucca I, Kwiatkowski M, Wirth GJ, Strebel RT, Engeler D, Pedrazzini A, Hüttenbrink C, Schultze-Seemann W, Torpai R, Bubendorf L, Wicki A, Roth B, Bosshard P, Püschel H, Boll DT, Hefermehl L, Roghmann F, et al. (2022). A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14. European Urology Oncology, 5(2), 195–202. https://doi.org/10.1016/j.euo.2021.12.006
